Inotiv, Inc. — Investor Relations & Filings
Inotiv, Inc. is a contract research organization (CRO) providing a comprehensive range of nonclinical and analytical drug discovery and development services. Key service areas include general toxicology, pathology, histology, drug metabolism and pharmacokinetics (DMPK), and bioanalytical solutions. The company also offers specialized services such as digital pathology with AI-driven image analysis, monoclonal antibody production, and developmental and reproductive toxicology (DART) studies. In addition to its CRO services, Inotiv is a major provider of research models and related products. This includes a wide array of animal models, genetically engineered model services (GEMS), contract breeding, surgical services, and Teklad laboratory animal diets and bedding. Inotiv serves clients across the pharmaceutical, biotechnology, medical device, academic, and government sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-06-03 | English | |
| 8-K | 2026-06-01 | English | |
| FORM 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-11 | English | |
| 8-K | 2026-05-05 | English | |
| 8-K | 2026-04-21 | English |
Browse filings by year
24 years- 2026 19 filings
- 2025 68 filings
- 2024 55 filings
- 2023 47 filings
- 2022 73 filings
- 2021 107 filings
- 2020 44 filings
- 2019 66 filings
- 2018 25 filings
- 2017 31 filings
- 2016 35 filings
- 2015 29 filings
- 2014 35 filings
- 2013 32 filings
- 2012 47 filings
- 2011 39 filings
- 2010 43 filings
- 2009 36 filings
- 2008 34 filings
- 2007 36 filings
- 2006 50 filings
- 2005 22 filings
- 2004 40 filings
- 2003 9 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47951133 | FORM 8-K | 2026-06-03 | English | ||
| 47916858 | 8-K | 2026-06-01 | English | ||
| 46385124 | FORM 8-K | 2026-05-18 | English | ||
| 46080184 | 10-Q | 2026-05-11 | English | ||
| 46080193 | 8-K | 2026-05-05 | English | ||
| 46080195 | 8-K | 2026-04-21 | English | ||
| 46080204 | 8-K | 2026-04-07 | English | ||
| 46080212 | 8-K | 2026-03-24 | English | ||
| 46080222 | 8-K | 2026-03-10 | English | ||
| 32880187 | 4 - INOTIV, INC. (0000720154) (Filer) | 2026-02-19 | English | ||
| 32880188 | 4 - INOTIV, INC. (0000720154) (Filer) | 2026-02-19 | English | ||
| 32880189 | 4 - INOTIV, INC. (0000720154) (Filer) | 2026-02-19 | English | ||
| 23373109 | 10-Q Filing | 2026-02-09 | English | ||
| 18222378 | 8-K Filing | 2026-02-09 | English | ||
| 18222377 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
RADIOPHARM THERANOSTICS LIMITED
Clinical-stage company developing radiopharmaceutical produ…
|
RAD | AU | Professional, scientific and te… |
|
Radiopharm Theranostics Ltd
Clinical-stage company developing radiopharmaceuticals for …
|
RADX | US | Professional, scientific and te… |
|
Rafael Holdings, Inc.
Invests in and develops therapies for cancer and rare genet…
|
RFL | US | Professional, scientific and te… |
|
Rain Enhancement Technologies Holdco, Inc.
Develops ionization-based weather modification technology f…
|
RAIN | US | Professional, scientific and te… |
|
Rakovina Therapeutics Inc.
Biopharma developing targeted cancer treatments using AI to…
|
RKV | CA | Professional, scientific and te… |
|
Rallybio Corp
A clinical-stage biotech company developing therapies for s…
|
RLYB | US | Professional, scientific and te… |
|
RaQualia Pharma Inc.
Develops and out-licenses innovative small molecule drug co…
|
4579 | JP | Professional, scientific and te… |
|
RECURSION PHARMACEUTICALS, INC.
A clinical-stage company applying AI and machine learning t…
|
RXRX | US | Professional, scientific and te… |
|
RELMADA THERAPEUTICS, INC.
Clinical-stage biotech developing therapies for bladder can…
|
RLMD | US | Professional, scientific and te… |
|
RenovoRx, Inc.
A clinical-stage company developing targeted oncology thera…
|
RNXT | US | Professional, scientific and te… |
Inotiv, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34595/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34595 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34595 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34595 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34595}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Inotiv, Inc. (id: 34595)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.